The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALLAKOS INC COM 01671P100   385,073 86,533 SH   SOLE   86,533 0 0
ALPS ETF TR ALERIAN MLP 00162Q452   1,140,175 29,500 SH   SOLE   29,500 0 0
BRIDGETOWN HOLDINGS LTD *W EXP 09/30/202 G1355U121   6,970 39,773 SH   SOLE   39,773 0 0
CABALETTA BIO INC COM 12674W109   335,602 40,581 SH   SOLE   40,581 0 0
COMPASS THERAPEUTICS INC COM 20454B104   675,451 211,740 SH   SOLE   211,740 0 0
ELEVATION ONCOLOGY INC COM 28623U101   129,815 68,324 SH   SOLE   68,324 0 0
LANVIN GROUP HOLDINGS LIMITE *W EXP 01/14/202 G5380J118   4,500 12,000 SH   SOLE   12,000 0 0
MOLECULAR TEMPLATES INC COM 608550109   779,931 2,052,991 SH   SOLE   2,052,991 0 0
NEWAMSTERDAM PHARMA COMPANY *W EXP 11/22/202 N62509117   40,533 21,333 SH   SOLE   21,333 0 0
REZOLUTE INC COM NEW 76200L309   2,694,061 1,403,157 SH   SOLE   1,403,157 0 0
SAVARA INC COM 805111101   13,448,274 6,896,551 SH   SOLE   6,896,551 0 0
SPDR S&P 500 ETF TR TR UNIT 78462F103   6,528,542 15,947 SH   SOLE   15,947 0 0
SPDR SER TR S&P OILGAS EXP 78468R556   2,232,825 17,500 SH   SOLE   17,500 0 0
VECTIVBIO HLDG AG ORD SHS H9060V101   1,345,549 156,651 SH   SOLE   156,651 0 0
XERIS BIOPHARMA HOLDINGS INC COM 98422E103   9,843,616 6,039,028 SH   SOLE   6,039,028 0 0